Covid-19与儿童多系统炎症综合征

IF 0.1 Q4 PERIPHERAL VASCULAR DISEASE

Revista Latinoamericana De Hipertension Pub Date : 2021-01-01 DOI:10.5281/zenodo.5514078

A. Alvarez, A. C. S. Urdiales, I. Velez, B. P. Melan, M. Carreño, I. G. Fajardo

{"title":"Covid-19与儿童多系统炎症综合征","authors":"A. Alvarez, A. C. S. Urdiales, I. Velez, B. P. Melan, M. Carreño, I. G. Fajardo","doi":"10.5281/zenodo.5514078","DOIUrl":null,"url":null,"abstract":"Although the pediatric population has shown lower morbidity and mortality by COVID-19, the younger age groups are not exempt from contracting COVID-19. Cases of children with clinical presentations resembling Kawasaki disease and toxic shock syndrome have been reported during the COVID-19 pandemic. This entity has been classified as the multisystem inflammatory syndrome in children (MISC) associated with COVID-19. The MISC is a phenotypically distinct entity, also caused by SARS-CoV-2, which tends to appear 2-6 weeks after the resolution of COVID-19. Although MIS-C is infrequent, it may have higher mortality than COVID-19 itself, and thus, early diagnosis and correct management is essential in order to offer the best care. Although at present time no management protocols for MIS-C are internationally accepted, research is in constant evolution to identify the best therapeutic alternatives. The aim of this article is to evaluate the clinical and epidemiological characteristics of MIS-C.","PeriodicalId":49606,"journal":{"name":"Revista Latinoamericana De Hipertension","volume":"15 1","pages":"168-172"},"PeriodicalIF":0.1000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Covid-19 and multisystem inflammatory syndrome in children\",\"authors\":\"A. Alvarez, A. C. S. Urdiales, I. Velez, B. P. Melan, M. Carreño, I. G. Fajardo\",\"doi\":\"10.5281/zenodo.5514078\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although the pediatric population has shown lower morbidity and mortality by COVID-19, the younger age groups are not exempt from contracting COVID-19. Cases of children with clinical presentations resembling Kawasaki disease and toxic shock syndrome have been reported during the COVID-19 pandemic. This entity has been classified as the multisystem inflammatory syndrome in children (MISC) associated with COVID-19. The MISC is a phenotypically distinct entity, also caused by SARS-CoV-2, which tends to appear 2-6 weeks after the resolution of COVID-19. Although MIS-C is infrequent, it may have higher mortality than COVID-19 itself, and thus, early diagnosis and correct management is essential in order to offer the best care. Although at present time no management protocols for MIS-C are internationally accepted, research is in constant evolution to identify the best therapeutic alternatives. The aim of this article is to evaluate the clinical and epidemiological characteristics of MIS-C.\",\"PeriodicalId\":49606,\"journal\":{\"name\":\"Revista Latinoamericana De Hipertension\",\"volume\":\"15 1\",\"pages\":\"168-172\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Latinoamericana De Hipertension\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5281/zenodo.5514078\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Latinoamericana De Hipertension","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.5514078","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

摘要

尽管儿童因COVID-19的发病率和死亡率较低，但较年轻的年龄组也不能免于感染COVID-19。在COVID-19大流行期间，报告了临床表现类似川崎病和中毒性休克综合征的儿童病例。该实体被归类为与COVID-19相关的儿童多系统炎症综合征(MISC)。MISC是一种表型不同的实体，也是由SARS-CoV-2引起的，往往在COVID-19消退后2-6周出现。虽然misc并不常见，但其死亡率可能高于COVID-19本身，因此，早期诊断和正确管理对于提供最佳护理至关重要。虽然目前国际上还没有公认的MIS-C管理方案，但研究仍在不断发展，以确定最佳的治疗方案。本文的目的是评价MIS-C的临床和流行病学特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Covid-19 and multisystem inflammatory syndrome in children

Although the pediatric population has shown lower morbidity and mortality by COVID-19, the younger age groups are not exempt from contracting COVID-19. Cases of children with clinical presentations resembling Kawasaki disease and toxic shock syndrome have been reported during the COVID-19 pandemic. This entity has been classified as the multisystem inflammatory syndrome in children (MISC) associated with COVID-19. The MISC is a phenotypically distinct entity, also caused by SARS-CoV-2, which tends to appear 2-6 weeks after the resolution of COVID-19. Although MIS-C is infrequent, it may have higher mortality than COVID-19 itself, and thus, early diagnosis and correct management is essential in order to offer the best care. Although at present time no management protocols for MIS-C are internationally accepted, research is in constant evolution to identify the best therapeutic alternatives. The aim of this article is to evaluate the clinical and epidemiological characteristics of MIS-C.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Latinoamericana De Hipertension 医学-外周血管病

CiteScore

0.40

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： La revista Latinoamericana de Hipertensión es una publicación biomédica periódica, arbitrada, de aparición trimestral, destinada a promover la productividad científica de la comunidad nacional e internacional en el área de Sistema Cardiovascular; así como todas aquellas publicaciones vinculadas a la medicina práctica en esta área. Su objetivo fundamental es la divulgación de artículos científicos y tecnológicos originales y artículos de revisión por invitación del Comité Editorial, asimismo, se admiten informes de investigaciones de corte cualitativo o cuantitativo; todos deben ser trabajos inéditos, no se hayan sometidos o hayan publicados en otra revista. El manuscrito debe ir acompañado de una carta solicitud firmada por el autor principal y el resto de los autores responsables del mismo. Está constituida por un Comité de redacción, organizado por Editor en Jefe, Editores Ejecutivos y Comité Editorial. Los manuscritos que publica pueden ser de autores nacionales o extranjeros, residentes o no en Venezuela, en castellano o en ingles (los resúmenes deben ser en ingles y castellano)